# OnCo record idea-cost-extended-interval-default (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-extended-interval-default/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-extended-interval-default" ;
  schema:name "Make six-weekly immunotherapy the default schedule"@en ;
  schema:description "Pembrolizumab 400 mg every six weeks is approved and works like 200 mg every three weeks, and it halves the number of clinic visits, infusion chairs and travel days without changing the drug bill."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-extended-interval-default/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dose-optimisation/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-workforce/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-017-nejm-2015/>, <https://onco.cc/key-papers/paper-keynote-189-nejm-2018/>, <https://onco.cc/key-papers/paper-keynote-564-nejm-2021/> .